Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial - Concepedia

Concepedia

Publication | Open Access

Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial

DOI Full Paper Access

38

Citations

33

References

2022

Year

Zoltán Bánki, José Mateus, Annika Rössler, Helena Schäfer, David Bante, Lydia Riepler, Alba Grifoni, Alessandro Sette, Viviana Simon, Barbara Falkensammer,

References

	Year	Citations

Page 1